BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rutherford ME, Hill PC, Triasih R, Sinfield R, van Crevel R, Graham SM. Preventive therapy in children exposed to Mycobacterium tuberculosis: problems and solutions. Trop Med Int Health 2012;17:1264-73. [PMID: 22862994 DOI: 10.1111/j.1365-3156.2012.03053.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Hirsch-Moverman Y, Howard AA, Frederix K, Lebelo L, Hesseling A, Nachman S, Mantell JE, Lekhela T, Maama LB, El-Sadr WM. The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trial. Trials 2017;18:552. [PMID: 29157275 DOI: 10.1186/s13063-017-2184-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mathad JS, Gupta A. Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin Infect Dis 2012;55:1532-49. [PMID: 22942202 DOI: 10.1093/cid/cis732] [Cited by in Crossref: 123] [Cited by in F6Publishing: 105] [Article Influence: 13.7] [Reference Citation Analysis]
3 Martinez L, Shen Y, Handel A, Chakraburty S, Stein CM, Malone LL, Boom WH, Quinn FD, Joloba ML, Whalen CC, Zalwango S. Effectiveness of WHO's pragmatic screening algorithm for child contacts of tuberculosis cases in resource-constrained settings: a prospective cohort study in Uganda. Lancet Respir Med 2018;6:276-86. [PMID: 29273539 DOI: 10.1016/S2213-2600(17)30497-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
4 Datiko DG, Yassin MA, Theobald SJ, Cuevas LE. A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia. Int J Tuberc Lung Dis 2017;21:1002-7. [PMID: 28826449 DOI: 10.5588/ijtld.16.0471] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
5 Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR; International Maternal Pediatric and Adolescents AIDS Clinical Trials Group., Tuberculosis Trials Consortium. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr 2015;169:247-55. [PMID: 25580725 DOI: 10.1001/jamapediatrics.2014.3158] [Cited by in Crossref: 108] [Cited by in F6Publishing: 88] [Article Influence: 18.0] [Reference Citation Analysis]
6 Triasih R, Robertson CF, Duke T, Graham SM. A prospective evaluation of the symptom-based screening approach to the management of children who are contacts of tuberculosis cases. Clin Infect Dis 2015;60:12-8. [PMID: 25270649 DOI: 10.1093/cid/ciu748] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
7 Zawedde-Muyanja S, Nakanwagi A, Dongo JP, Sekadde MP, Nyinoburyo R, Ssentongo G, Detjen AK, Mugabe F, Nakawesi J, Karamagi Y, Amuge P, Kekitiinwa A, Graham SM. Decentralisation of child tuberculosis services increases case finding and uptake of preventive therapy in Uganda. Int J Tuberc Lung Dis 2018;22:1314-21. [PMID: 30355411 DOI: 10.5588/ijtld.18.0025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
8 Teklay G, Teklu T, Legesse B, Tedla K, Klinkenberg E. Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study. BMC Public Health 2016;16:840. [PMID: 27543096 DOI: 10.1186/s12889-016-3525-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
9 Dorjee K, Topgyal S, Dorjee C, Tsundue T, Namdol T, Tsewang T, Nangsel T, Lhadon D, Choetso T, Dawa T, Phentok T, DeLuca AN, Tsering L, Phunkyi D, Sadutshang TD, J Bonomo E, Paster Z, Chaisson RE. High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee Children. Clin Infect Dis 2019;69:760-8. [PMID: 30462191 DOI: 10.1093/cid/ciy987] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
10 Kay AW, Thivalapill N, Skinner D, Dube GS, Dlamini N, Mzileni B, Fuentes P, Ustero P, Adams LV, Mandalakas AM. Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV. PLoS One 2020;15:e0243713. [PMID: 33332462 DOI: 10.1371/journal.pone.0243713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jenkins HE, Tolman AW, Yuen CM, Parr JB, Keshavjee S, Pérez-Vélez CM, Pagano M, Becerra MC, Cohen T. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 2014;383:1572-9. [PMID: 24671080 DOI: 10.1016/S0140-6736(14)60195-1] [Cited by in Crossref: 155] [Cited by in F6Publishing: 84] [Article Influence: 22.1] [Reference Citation Analysis]
12 Birungi FM, Graham S, Uwimana J, van Wyk B. Assessment of the Isoniazid Preventive Therapy Uptake and Associated Characteristics: A Cross-Sectional Study. Tuberc Res Treat 2018;2018:8690714. [PMID: 29854455 DOI: 10.1155/2018/8690714] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Vasiliu A, Eymard-Duvernay S, Tchounga B, Atwine D, de Carvalho E, Ouedraogo S, Kakinda M, Tchendjou P, Turyahabwe S, Kuate AK, Tiendrebeogo G, Dodd PJ, Graham SM, Cohn J, Casenghi M, Bonnet M. Community intervention for child tuberculosis active contact investigation and management: study protocol for a parallel cluster randomized controlled trial. Trials 2021;22:180. [PMID: 33653385 DOI: 10.1186/s13063-021-05124-9] [Reference Citation Analysis]
14 Mendonça AMC, Kritski AL, Sant’anna CC. Tuberculosis contact tracing among children and adolescent referred to children's hospital in Rio de Janeiro, Brazil. The Brazilian Journal of Infectious Diseases 2015;19:296-301. [DOI: 10.1016/j.bjid.2014.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Graham SM. The management of infection with Mycobacterium tuberculosis in young children post-2015: an opportunity to close the policy-practice gap. Expert Review of Respiratory Medicine 2017;11:41-9. [DOI: 10.1080/17476348.2016.1267572] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
16 Hall C, Sukijthamapan P, dos Santos R, Nourse C, Murphy D, Gibbons M, Francis JR. Challenges to delivery of isoniazid preventive therapy in a cohort of children exposed to tuberculosis in Timor-Leste. Trop Med Int Health 2015;20:730-6. [PMID: 25682846 DOI: 10.1111/tmi.12479] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
17 Marais BJ. Improving access to tuberculosis preventive therapy and treatment for children. Int J Infect Dis 2017;56:122-5. [PMID: 27993688 DOI: 10.1016/j.ijid.2016.12.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
18 Triasih R, Robertson C, Duke T, Graham SM. Risk of infection and disease with Mycobacterium tuberculosis among children identified through prospective community-based contact screening in Indonesia. Trop Med Int Health 2015;20:737-43. [DOI: 10.1111/tmi.12484] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
19 Seddon JA, Whittaker E, Kampmann B, Lewinsohn DA, Osman M, Hesseling AC, Rustomjee R, Amanullah F. The evolving research agenda for paediatric tuberculosis infection. Lancet Infect Dis 2019;19:e322-9. [PMID: 31221543 DOI: 10.1016/S1473-3099(18)30787-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
20 Chandra DK, Moll AP, Altice FL, Didomizio E, Andrews L, Shenoi SV. Structural barriers to implementing recommended tuberculosis preventive treatment in primary care clinics in rural South Africa. Glob Public Health 2021;:1-14. [PMID: 33650939 DOI: 10.1080/17441692.2021.1892793] [Reference Citation Analysis]
21 Becerra MC, Swaminathan S. Commentary: a targets framework: dismantling the invisibility trap for children with drug-resistant tuberculosis. J Public Health Policy 2014;35:425-54. [PMID: 25209537 DOI: 10.1057/jphp.2014.35] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
22 Otero L, Battaglioli T, Ríos J, De la Torre Z, Trocones N, Ordoñez C, Seas C, Van der Stuyft P. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data. Trop Med Int Health 2020;25:346-56. [PMID: 31758837 DOI: 10.1111/tmi.13350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
23 Salazar-Austin N, Cohn S, Barnes GL, Tladi M, Motlhaoleng K, Swanepoel C, Motala Z, Variava E, Martinson N, Chaisson RE. Improving Tuberculosis Preventive Therapy Uptake: A Cluster-randomized Trial of Symptom-based Versus Tuberculin Skin Test-based Screening of Household Tuberculosis Contacts Less Than 5 Years of Age. Clin Infect Dis 2020;70:1725-32. [PMID: 31127284 DOI: 10.1093/cid/ciz436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Mueller-Hermelink M, Kobbe R, Methling B, Rau C, Schulze-Sturm U, Auer I, Ahrens F, Brinkmann F. Universal screening for latent and active tuberculosis (TB) in asylum seeking children, Bochum and Hamburg, Germany, September 2015 to November 2016. Euro Surveill 2018;23. [PMID: 29589578 DOI: 10.2807/1560-7917.ES.2018.23.12.17-00536] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
25 Laghari M, Sulaiman SAS, Khan AH, Talpur BA, Bhatti Z, Memon N. Contact screening and risk factors for TB among the household contact of children with active TB: a way to find source case and new TB cases. BMC Public Health 2019;19:1274. [PMID: 31533689 DOI: 10.1186/s12889-019-7597-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
26 Lestari T, Graham S, van den Boogard C, Triasih R, Poespoprodjo JR, Ubra RR, Kenangalem E, Mahendradhata Y, Anstey NM, Bailie RS, Ralph AP. Bridging the knowledge-practice gap in tuberculosis contact management in a high-burden setting: a mixed-methods protocol for a multicenter health system strengthening study. Implement Sci 2019;14:31. [PMID: 30890160 DOI: 10.1186/s13012-019-0870-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Egere U, Sillah A, Togun T, Kandeh S, Cole F, Jallow A, Able-Thomas A, Hoelscher M, Heinrich N, Hill PC, Kampmann B. Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The Gambia. Public Health Action 2016;6:226-31. [PMID: 28123958 DOI: 10.5588/pha.16.0073] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
28 Skinner D, Hesseling AC, Francis C, Mandalakas AM. It's hard work, but it's worth it: the task of keeping children adherent to isoniazid preventive therapy. Public Health Action 2013;3:191-8. [PMID: 26393028 DOI: 10.5588/pha.13.0010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
29 Gwee A, Coghlan B, Curtis N. Question 1: what are the options for treating latent TB infection in children? Arch Dis Child 2013;98:468-74. [PMID: 23661667 DOI: 10.1136/archdischild-2013-303876] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
30 Graham SM, Triasih R. Editorial commentary: more evidence to support screening of child contacts of tuberculosis cases: if not now, then when? Clin Infect Dis 2013;57:1693-4. [PMID: 24077056 DOI: 10.1093/cid/cit647] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
31 Jo Y, Gomes I, Flack J, Salazar-Austin N, Churchyard G, Chaisson RE, Dowdy DW. Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries. EClinicalMedicine 2021;31:100707. [PMID: 33554088 DOI: 10.1016/j.eclinm.2020.100707] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Stagner WC, Iyer M, Rathod V, Meruva S, Staton S, Haware RV. Human volunteer, in vitro, and molecular level evaluation of an optimized taste-masked isoniazid-chitosan spray-dried microparticle matrix. International Journal of Pharmaceutics 2019;572:118774. [DOI: 10.1016/j.ijpharm.2019.118774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]